NFKBIA and prostate carcinoma: Curcumin (33) was reported to increase the susceptibility of prostate cancer LNCaP cells to TNFRSF10A by inhibiting NFKB stimulation through hindering phosphorylation of NFKBIA/IκBα and its degradation [302].